Neurocrine Biosciences Gears Up to Showcase Developments at the 2026 Jefferies Global Healthcare Conference

SAN DIEGO, Nov. 10, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that its executives will participate at the 2026 Jefferies Global Healthcare Conference in London at 3:30 p.m. Greenwich Mean Time (10:30 a.m. Eastern Time) on November…